IQVIA Holdings Inc.
- IQV
- NYSE
- Medical - Diagnostics & Research
- Healthcare Data Analytics
- Clinical Research (CRO)
- Life Sciences Technology
$266.90
Today −1.53%Quote Oct 16, 2026, 08:02 PM UTC
−0.94%over the last month
Max drawdown −6.1%From 1-month high −3.0%3 months +30.9%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$43.93B
Quote Oct 16
Next earnings
Oct 27
Expected, not confirmed
Analyst target
$284.64
+6.6% from here
Floor
$262.24
1.7% below price
Where the price sits
45 analysts
Analyst range, low to high
$240.00$345.00
- Price $266.90
- Resistance $271.14–$273.86
- Consensus $284.64
The price is just above its floor and right under resistance. Analysts' average target sits about 7% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about IQVPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
Q2 2026 revenue $4.37B
- Research & Development Solutions$2.58B59.0%
- Commercial Solutions$1.79B41.0%
Industry
Medical - Diagnostics & Research
Employees
94,000
Founded
1982